BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
AudioCure Pharma
/
Dr. Reimar Schlingensiepen, MD
DR
Dr. Reimar Schlingensiepen, MD
Chief Executive Officer
AudioCure Pharma
Therapeutic Areas
Otology
Neurology
AudioCure Pharma Pipeline
Drug
Indication
Phase
AC102
Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)
Phase 2
Leadership Team at AudioCure Pharma
PH
Prof. Hans Rommelspacher, MD
Chief Scientific Officer and Founder
View full AudioCure Pharma profile